N,N-二甲基-N-辛基氯化1-癸铵 | 32426-11-2

• 物质功能分类: 医药中间体
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: N,N-二甲基-N-辛基氯化1-癸铵
• 中文别名: 八烷基二甲基氯化铵；癸基二甲基氯化铵；辛基癸基二甲基氯化铵；季铵盐-24；十烷基二甲基氯化铵；辛基二甲基氯化铵
• 英文名称: Decyldimethyloctylammonium chloride
• 英文别名: decyl-dimethyl-octylazanium;chloride
• CAS: 32426-11-2
• 化学式: C20H44ClN
• 分子量: 334.0
• InChiKey: SCXCDVTWABNWLW-UHFFFAOYSA-M

物化性质

• 溶解度：
  可溶于氯仿（少许）、DMSO（少许）、甲醇（少许）
• 物理描述：
  Liquid

计算性质

• 辛醇/水分配系数(LogP)：
  3.57
• 重原子数：
  22
• 可旋转键数：
  16
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

ADMET

毒理性

• 副作用

Dermatotoxin - 皮肤烧伤。

Dermatotoxin - Skin burns.

来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

制备方法与用途

用途

辛基癸基二甲基氯化铵是一种抗菌剂，可用于制备各种消毒液。

作用

辛基癸基二甲基氯化铵也可作为有机化工中间体。

生产方法

由辛癸基甲基叔胺与氯甲烷进行季铵化反应制得。

反应信息

• 作为反应物：
  描述：

  N,N-二甲基-N-辛基氯化1-癸铵 生成 双辛、癸烷基甲基叔胺
  参考文献：
  名称：

  NEWKOME G. R.; MAJESTIC V. K.; SAUER J. D., ORG. PREP. AND PROCED. INT., 1980, 12, NO 6, 345-350

  摘要：

  DOI：

文献信息

• BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
  申请人：SENOMYX, INC.

  公开号：US20160376263A1

  公开（公告）日：2016-12-29

  The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.

  本发明涵盖已知用于改变苦味感知的化合物和组合物，以及所述组合物和化合物与额外的组合物、化合物和产品的组合。示例组合物包括以下一种或多种：冷却剂；无活性药物成分；活性药用成分；食品添加剂或食品；调味剂或调味增强剂；食品或饮料产品；苦味化合物；甜味剂；苦味剂；酸味调味剂；咸味调味剂；鲜味调味剂；植物或动物产品；已知用于宠物护理产品中的化合物；已知用于个人护理产品中的化合物；已知用于家用产品中的化合物；制药制剂；局部制剂；大麻衍生或与大麻相关的产品；已知用于口腔护理产品中的化合物；饮料；香味、香水或除臭剂；已知用于消费品中的化合物；硅化合物；磨料；表面活性剂；发热剂；吸烟物品；脂肪、油脂或乳化剂；和/或益生菌或补充剂。
• Process for the preparation cyano carboxylic acid esters
  申请人：Lonza Ltd

  公开号：EP2455365A1

  公开（公告）日：2012-05-23

  The present invention relates to a process for the preparation of a cyano carboxylic acid ester of the formula wherein R1 is a linear or branched C1-8 alkanediyl group; and R2 is a linear or branched alkyl group, a cycloalkyl group, or an aryl or arylalkyl group, wherein aryl is optionally substituted with one or more C1-8 alkyl groups; comprising reacting a halo carboxylic acid ester of the formula wherein R1 and R2 are as defined above; and Hal is fluorine, chlorine, bromine or iodine; in a reaction mixture comprising a homogeneous liquid phase, wherein the liquid phase consists of water and an organic solvent, with an alkali metal cyanide in the presence of hydrogen cyanide, optionally in the presence of a catalyst, to obtain the cyano carboxylic acid ester of the formula (I).

  本发明涉及一种制备氰基羧酸酯的过程，其化学式为其中R1是直链或支链的C1-8烷二基基团；R2是直链或支链的烷基团、环烷基团或芳基或芳基烷基团，其中芳基可以选择性地与一个或多个C1-8烷基团取代；包括在反应混合物中反应化学式为的卤代羧酸酯其中R1和R2如上定义；Hal是氟、氯、溴或碘；在包含均相液相的反应混合物中，液相由水和有机溶剂组成，与碱金属氰化物在氢氰的存在下反应，可选地在催化剂的存在下，以获得化学式（I）的氰基羧酸酯。
• [EN] APP SPECIFIC BACE INHIBITORS (ASBIs) AND USES THEREOF<br/>[FR] INHIBITEURS DE BACE SPÉCIFIQUES DE L'APP (ASBI) ET LEURS UTILISATIONS
  申请人：JOHN VARGHESE

  公开号：WO2013142370A1

  公开（公告）日：2013-09-26

  In certain embodiments APP-specific BACE inhibitors (ASBIs) are provided as well as uses thereof. In certain embodiments methods of preventing or delaying the onset of a pre-Alzheimer's condition and/or cognitive dysfunction, and/or ameliorating one or more symptoms of a pre-Alzheimer's condition and/or cognitive dysfunction, or preventing or delaying the progression of a pre-Alzheimer's condition or cognitive dysfunction to Alzheimer's disease are provided where the method involves administering to a subject in need thereof an APP specific BACE inhibitor (ASBI) in an amount sufficient to prevent or delay the onset of a pre-Alzheimer's cognitive dysfunction, and/or to ameliorate one or more symptoms of a pre-Alzheimer's cognitive dysfunction, and/or to prevent or delay the progression of a pre-Alzheimer's cognitive dysfunction to Alzheimer's disease. In certain embodiments the ASBI is a flavonoid (e.g. galangin) or flavonoid progrug (e.g., galangin prodrug).

  在某些实施例中，提供了特定于APP的BACE抑制剂（ASBI）以及其用途。在某些实施例中，提供了预防或延迟早期阿尔茨海默病症状和/或认知功能障碍的方法，以及改善早期阿尔茨海默病症状和/或认知功能障碍的一种或多种症状，或预防或延迟早期阿尔茨海默病症状或认知功能障碍发展为阿尔茨海默病的方法，其中该方法涉及向需要的受试者施用足以预防或延迟早期阿尔茨海默病认知功能障碍发作的APP特异性BACE抑制剂（ASBI）的剂量，和/或改善早期阿尔茨海默病认知功能障碍的一种或多种症状，和/或预防或延迟早期阿尔茨海默病认知功能障碍发展为阿尔茨海默病。在某些实施例中，ASBI是一种黄酮类化合物（例如，没药酮）或黄酮类化合物前药（例如，没药酮前药）。
• [EN] MTORC MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE MTORC ET LEURS UTILISATIONS
  申请人：AEOVIAN PHARMACEUTICALS INC

  公开号：WO2020154447A1

  公开（公告）日：2020-07-30

  Novel rapamycin analogs and uses thereof are disclosed herein. The rapamycin analogs of the present disclosure show increased mTORC1 specificity and lowered mTORC2 specificity relative to rapamycin.

  本文披露了新型雷帕霉素类似物及其用途。本公开的雷帕霉素类似物相对于雷帕霉素表现出增加的mTORC1特异性和降低的mTORC2特异性。
• COMPOUNDS USEFUL AS MODULATORS OF TRPM8
  申请人：Senomyx, Inc.

  公开号：US20170096418A1

  公开（公告）日：2017-04-06

  The present disclosure relates to compounds which are useful as cooling sensation compounds.

  本公开涉及作为冷感化合物有用的化合物。